Creating access to expert knowledge from China

China Access Bootcamp was successful – virtual delegation trip to follow

The "China Access Bootcamp", organized by the MAGIA2Market project partners and Life Science Nord, took place from March 1 to 3. The three-day online event enabled participants to get an in-depth understanding of the Chinese MedTech market and contributes to their ability to strategically prepare their market entry. The focus of the presentations and discussions was on topics such as the regulation of medical devices as well as financing options and intellectual property rights. The bootcamp was part of the preparation for a virtual delegation trip to China, an activity within the framework of the EU-funded project MAGIA2Market at the end of March 2022.

3 modules for know-how transfer

Together with the two Chinese partners, the Research Institute of Tsinghua University in Shenzhen (RITS) and Leaguer Bio-Tech, participants from interested life science companies had the opportunity to take part in the three modules

  • Shenzhen's Business Environment and Internationalization – Overview of medical device regulations in China
  • Basic legal knowledge and provisions of international cooperation
  • IP Protection – Investment & Financing

to benefit from the knowledge of regional experts and to gain a broad but also detailed insight into the Chinese market. For those who participated, joining the online bootcamp was well worth it. "The Chinese market is a large market for us and having this great opportunity to learn more about the market and its regulations is a good preparation as we start to address its potential," emphasized participant Simon Myrbäck, Business Development Manager, Cellbox Solutions GmbH. In addition to Cellbox Solutions, Life Science Nord members Anacyte Laboratories GmbH and m-u-t GmbH also used the opportunity to take part in the market know-how of the bootcamp's speakers and as preparation for their upcoming participation in the virtual journey.

Sarah Niemann, Manager International Affairs at Life Science Nord, supports companies from the LSN cluster in internationalization projects as part of MAGIA2Market.

"The Access Bootcamp was a successful kick-off for the virtual delegation trip to China that is coming up soon. The knowledge imparted enables the companies to better assess how they should proceed with a possible market entry. With the delegation trip, we want to give the companies traveling with us the opportunity to set foot in the Chinese life science market in a very concrete way," says Sarah Niemann, Manager International Affairs at Life Science Nord, who is actively promoting networking activities between Europe and China together with the MAGIA2Market project partners.

More News

Bastian Rouven Brückner, Head of Operations, Merck Group/AmpTec GmbH, Peter Scheinert, Founder & CEO, AmpTec GmbH, Prof. Simone Spuler, Head of the Myology Lab at the Experimental and Clinical Research Center (ECRC), Dr. Matthias Jöhnck, Senior Director m
Bastian Rouven Brückner, Head of Operations, Merck Group/AmpTec GmbH, Peter Scheinert, Founder & CEO, AmpTec GmbH, Prof. Simone Spuler, Head of the Myology Lab at the Experimental and Clinical Research Center (ECRC), Dr. Matthias Jöhnck, Senior Director mRNA Value Chain, Synthesis & ADC, Merck Life Science Services and MD AmpTec GmbH and Tanja Stadie, Head Of Quality, Merck Group/AmpTec GmbH at the official opening of the new mRNA production facility in Hamburg. (from left - Image: Merck KGaA)

Merck/AmpTec: New mRNA manufacturing site opened in Hamburg

Merck, a leading science and technology company, today became the first CTDMO (contract testing, development and manufacturing organization) to offer integrated services for all critical ...

Read more …
Cellbox Ground 2.0 ushers in a new era of cell shipping: Live Cell Shipping.
Cellbox Ground 2.0 ushers in a new era of cell shipping: Live Cell Shipping. (Image: Cellbox Solutions)

Cellbox Solutions Awarded €2.5 Million Grant

Cellbox Solutions GmbH, a leading provider of warm chain logistics solutions for the research, development and shipment of cell-based therapies and cellular diagnostics, today announced ...

Read more …